Cargando…
Eltrombopag directly activates BAK and induces apoptosis
Small molecule direct BAK activators can potentially be used for the development of anti-cancer drugs or as tools to study BAK activation. The thrombopoietin receptor agonist eltrombopag (Eltro) inhibits BAX activation and BAX-mediated apoptosis. Here we report that, in contrast to its function as a...
Autores principales: | Chen, Meng, Hu, Lei, Bao, Xuyuan, Ye, Kaiqin, Li, Yunjian, Zhang, Zhiyong, Kaufmann, Scott H., Xiao, Jun, Dai, Haiming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10314921/ https://www.ncbi.nlm.nih.gov/pubmed/37393297 http://dx.doi.org/10.1038/s41419-023-05918-6 |
Ejemplares similares
-
Characterization of an alternative BAK-binding site for BH3 peptides
por: Ye, Kaiqin, et al.
Publicado: (2020) -
Bak Conformational Changes Induced by Ligand Binding: Insight into BH3 Domain Binding and Bak Homo-Oligomerization
por: Pang, Yuan-Ping, et al.
Publicado: (2012) -
Transient binding of an activator BH3 domain to the Bak BH3-binding groove initiates Bak oligomerization
por: Dai, Haiming, et al.
Publicado: (2011) -
Constitutive BAK activation as a determinant of drug sensitivity in malignant lymphohematopoietic cells
por: Dai, Haiming, et al.
Publicado: (2015) -
Constitutive BAK/MCL1 complexes predict paclitaxel and S63845 sensitivity of ovarian cancer
por: Liu, Dongyan, et al.
Publicado: (2021)